Carnegie Capital Asset Management »

Anavex Life Sciences shares owned by Carnegie Capital Asset Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Carnegie Capital Asset Management from 13F filings

Historical chart of Carnegie Capital Asset Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Carnegie Capital Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $686k 74k 9.31
2023-09-30 $442k 67k 6.55
2023-06-30 $553k 68k 8.13
2023-03-31 $374k 44k 8.57
2022-12-31 $174k 19k 9.26